Shareholders' (Deficit) Equity - Exchange Agreement (Details) - $ / shares |
3 Months Ended | |
---|---|---|
Feb. 28, 2024 |
Mar. 31, 2024 |
|
Pre-funded warrants | ||
Class of Warrant or Right | ||
Purchase price | $ 1.499 | |
Warrants issued to purchase shares | 3,333,333 | |
Warrants exercise price | $ 0.001 | |
Pre-funded warrants | Maximum | ||
Class of Warrant or Right | ||
Number of shares issued during the period | 3,000,000 | |
Common Shares | ||
Class of Warrant or Right | ||
Number of shares issued during the period | 19,666,667 |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|